STOCK TITAN

Xencor director Ranieri sells 81,252 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Xencor director Richard J. Ranieri exercised stock options covering 75,755 shares on November 10, 2026, at exercise prices of $9.43, $21.31, $23.04 and $26.58 per share, acquiring the corresponding common shares. He also sold 81,252 shares: 70,080 at a weighted-average $39.20 per share and 11,172 at a weighted-average $39.59. No Rule 10b5-1 plan is reported.

Insider RANIERI RICHARD J
Role Director
Sold 81,252 shs ($3.19M)
Approx. gross sale proceeds $3.19M
Approx. exercise cost $1.43M
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F3 15,000 $0.00 $0.00
Exercise Stock Option (Right to Buy) F4 21,412 $0.00 $0.00
Exercise Stock Option (Right to Buy) F5 11,971 $0.00 $0.00
Exercise Stock Option (Right to Buy) F6 27,372 $0.00 $0.00
Exercise Common Stock 15,000 $23.04 $346K
Exercise Common Stock 21,412 $26.58 $569K
Exercise Common Stock 11,971 $21.31 $255K
Exercise Common Stock 27,372 $9.43 $258K
Sale Common Stock F1 70,080 $39.20 $2.75M
Sale Common Stock F2 11,172 $39.59 $442K
Holdings After Transaction: Stock Option (Right to Buy) — 0 options (Direct); Common Stock — 18,514 shares (Direct)
Footnotes (6)
  1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.51 to $39.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. F3. 25% of the shares subject to the option vested on the one year anniversary of December 18, 2017 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
  4. F4. 25% of the shares subject to the option vested on the one year anniversary of June 23, 2022 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
  5. F5. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 13, 2024, such that the total number of shares was fully vested on June 13, 2025.
  6. F6. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares was fully vested on June 12, 2026.
Options exercised 75,755 shares November 10, 2026
Exercise price $23.04 per share Options covering 15,000 shares exercised November 10, 2026
Exercise price $26.58 per share Options covering 21,412 shares exercised November 10, 2026
Exercise price $21.31 per share Options covering 11,971 shares exercised November 10, 2026
Exercise price $9.43 per share Options covering 27,372 shares exercised November 10, 2026
Shares sold 81,252 shares November 10, 2026
Weighted-average sale price $39.20 per share 70,080 shares sold November 10, 2026
Weighted-average sale price $39.59 per share 11,172 shares sold November 10, 2026
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Vesting Commencement Date technical
"the one year anniversary of December 18, 2017 (the "Vesting Commencement Date")"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many XNCR shares did Richard J. Ranieri sell, and at what prices?

Richard J. Ranieri sold 70,080 shares at a weighted-average $39.20 per share and 11,172 shares at a weighted-average $39.59 per share on November 10, 2026. The reported execution ranges were $38.50–$39.50 and $39.51–$39.76 per share, respectively. No Rule 10b5-1 plan is reported.

How many options did XNCR director Richard J. Ranieri exercise?

On November 10, 2026, Ranieri exercised options covering 15,000 shares at $23.04, 21,412 at $26.58, 11,971 at $21.31 and 27,372 at $9.43 per share, acquiring the corresponding numbers of common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RANIERI RICHARD J

(Last)(First)(Middle)
C/O XENCOR, INC.
465 N HALSTEAD STREET, SUITE 200

(Street)
PASADENA CALIFORNIA 91107

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Xencor Inc [ XNCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/10/2026M15,000A$23.0439,011D
Common Stock11/10/2026M21,412A$26.5860,423D
Common Stock11/10/2026M11,971A$21.3172,394D
Common Stock11/10/2026M27,372A$9.4399,766D
Common Stock11/10/2026S70,080D$39.2(1)29,686D
Common Stock11/10/2026S11,172D$39.59(2)18,514D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$23.0411/10/2026M15,000 (3)12/18/2027Common Stock15,000$00D
Stock Option (Right to Buy)$26.5811/10/2026M21,412 (4)06/23/2032Common Stock21,412$00D
Stock Option (Right to Buy)$21.3111/10/2026M11,971 (5)06/13/2034Common Stock11,971$00D
Stock Option (Right to Buy)$9.4311/10/2026M27,372 (6)06/12/2035Common Stock27,372$00D
Explanation of Responses:
1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $39.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.51 to $39.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. 25% of the shares subject to the option vested on the one year anniversary of December 18, 2017 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
4. 25% of the shares subject to the option vested on the one year anniversary of June 23, 2022 (the "Vesting Commencement Date"), and 1/48th of the shares vested monthly thereafter, such that the option was fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.
5. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 13, 2024, such that the total number of shares was fully vested on June 13, 2025.
6. The shares subject to the option vested in equal monthly installments over one year beginning on the one-month anniversary of June 12, 2025, such that the total number of shares was fully vested on June 12, 2026.
Remarks:
/s/ Celia E. Eckert, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading